All supplements

Supplement evidence

111 / 575Joint & connective tissue

Undenatured type II collagen (UC-II)

View my plan

The short answer

Small trials suggest improvement in knee symptoms; it is not interchangeable with collagen peptides.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding
Key concern: Chicken allergy, autoimmune disease, pregnancy, and product identity require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Joint symptoms40 mg/day branded undenatured type II collagen in many trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat/water classification is not the key factor

Fat/water solubility is not the useful decision point; preparation, fluid, timing, or strain identity matters more.

How it is commonly taken

Take consistently according to the studied product.

Do not combine casually

Chicken allergy, autoimmune disease, pregnancy, and product identity require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger
8unique primary studies represented
unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2023
Mixed or qualifiedPMID 37854210

Undenatured type II collagen for early knee osteoarthritis

Pain, WOMAC, and some walking measures favored UC-II, but the authors described the literature as limited and called for larger trials. The incomplete full participant total is not inferred, and symptom changes do not establish cartilage repair or disease modification.

Study design and methods
Design
Systematic review with limited meta-analysis of 8 randomized trials
Population
Adults with early knee osteoarthritis; 243 received UC-II, but the full control-group total was not reported in the abstract
Intervention
Undenatured type II collagen versus placebo or control
Outcome
Pain, WOMAC, knee function, walking tests, range of motion, and complications

Funding or conflict note: The review reported no conflicts of interest.

Open research record
Unscreened discovery appendix—not evidence11 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Efficacy and tolerability of native (undenatured) type II collagen supplementation for joint health in healthy volunteers: a randomized double-blind placebo-controlled study.Möller I, Martínez K, Terradillos-Guillén A et al. · 2026 · Nutrition journal · PMID 41787523Open on PubMed
  2. Efficacy of combined undenatured type II collagen and hydrolysed collagen supplementation in knee osteoarthritis: a randomised controlled trial.Yuenyongviwat V, Anusitviwat C, Tuntarattanapong P et al. · 2025 · Scientific reports · PMID 40897777Open on PubMed
  3. Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis.Chen CS, Wen L, Yang F et al. · 2025 · Journal of integrative medicine · PMID 40425393Open on PubMed
  4. [Experience with the use of undenatured type II collagen in patients with stage III knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].Alekseeva LI, Kashevarova NG, Taskina EA et al. · 2025 · Terapevticheskii arkhiv · PMID 40237733Open on PubMed
  5. [Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].Alekseeva LI, Kashevarova NG, Taskina EA et al. · 2024 · Terapevticheskii arkhiv · PMID 38829812Open on PubMed
  6. [Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D(3) and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint].Mazurov VI, Belyaeva IB, Trofimov EA et al. · 2023 · Terapevticheskii arkhiv · PMID 38785054Open on PubMed
  7. Efficacy and Safety of Dietary Undenatured Type II Collagen on Joint and Motor Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.Shiojima Y, Takahashi M, Takahashi R et al. · 2023 · Journal of the American Nutrition Association · PMID 35512781Open on PubMed
  8. UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study.Schön C, Knaub K, Alt W et al. · 2022 · Journal of integrative and complementary medicine · PMID 35377244Open on PubMed
  9. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.Liu X, Machado GC, Eyles JP et al. · 2018 · British journal of sports medicine · PMID 29018060Open on PubMed
  10. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.Lugo JP, Saiyed ZM, Lane NE · 2016 · Nutrition journal · PMID 26822714Open on PubMed
  11. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.Crowley DC, Lau FC, Sharma P et al. · 2009 · International journal of medical sciences · PMID 19847319Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.